QuidelOrtho (QDEL) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
QuidelOrtho is the larger company by market cap ($920.3 million vs $6.4 million), about 144.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QDEL | VNRX |
|---|---|---|
| Share price | $13.42 | $0.2113 |
| Market cap | $920.28M | $6.35M |
| 1-day change | +8.14% | -3.69% |
| YTD return | -53.01% | — |
| 1-year return | -52.17% | — |
| 5-year return | -89.54% | — |
| Forward P/E | 9.31 | — |
| EPS (TTM) | $-15.39 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $35.58 | $10.40 |
| 52-week low | $9.92 | $0.2113 |
| Distance from 52-week high | -62.28% | -97.97% |
| Analyst consensus | hold | none |
| Avg. price target upside | +9.31% | +6345.81% |
| Average volume | 1.51M | 8.47M |
| Shares outstanding | 68.58M | 30.06M |
| Employees | 6,500 | 57 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QuidelOrtho is about 144.9 times larger than VolitionRX by market value ($920.28M vs $6.35M).
About QuidelOrtho
QDEL stock →QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 6,500 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 57 employees
QDEL vs VNRX FAQ
Which is bigger, QuidelOrtho or VolitionRX?
QuidelOrtho (QDEL) is larger, with a market capitalization of $920.28M compared with $6.35M for VolitionRX (VNRX).
Are QuidelOrtho and VolitionRX in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.